# Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function

> **NCT05470725** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 33 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** CIN-107

## Key facts

- **NCT ID:** NCT05470725
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-12
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05470725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05470725, "Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05470725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*